These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 220107)

  • 41. Widespread flat warts associated with human papillomavirus type 5: a cutaneous manifestation of human immunodeficiency virus infection.
    Prose NS; von Knebel-Doeberitz C; Miller S; Milburn PB; Heilman E
    J Am Acad Dermatol; 1990 Nov; 23(5 Pt 2):978-81. PubMed ID: 2172338
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Severe intractable common warts associated with human papillomavirus 2, 3 and 20.
    Tanigaki T; Kanda R
    Dermatologica; 1990; 181(2):159-61. PubMed ID: 2173668
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin.
    Majewski S; Jabłońska S
    Arch Dermatol; 1995 Nov; 131(11):1312-8. PubMed ID: 7503577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of three distinct papillomavirus genomes in a single patient with epidermodysplasia verruciformis.
    Ostrow RS; Watts S; Bender M; Niimura M; Seki T; Kawashima M; Pass F; Faras AJ
    J Am Acad Dermatol; 1983 Mar; 8(3):398-404. PubMed ID: 6300202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation between human papillomavirus (HPV) type and histology of warts.
    Gross G; Pfister H; Hagedorn M; Gissmann L
    J Invest Dermatol; 1982 Feb; 78(2):160-4. PubMed ID: 6276473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The presence of antibodies against virus-like particles of epidermodysplasia verruciformis-associated humanpapillomavirus type 8 in patients with actinic keratoses.
    Bouwes Bavinck JN; Stark S; Petridis AK; Marugg ME; Ter Schegget J; Westendorp RG; Fuchs PG; Vermeer BJ; Pfister H
    Br J Dermatol; 2000 Jan; 142(1):103-9. PubMed ID: 10651702
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Case-control study in a subtropical Australian population to assess the relation between non-melanoma skin cancer and epidermodysplasia verruciformis human papillomavirus DNA in plucked eyebrow hairs. The Nambour Skin Cancer Prevention Study Group.
    Boxman IL; Russell A; Mulder LH; Bavinck JN; Schegget JT; Green A
    Int J Cancer; 2000 Apr; 86(1):118-21. PubMed ID: 10728604
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Histopathology of skin lesions in renal allograft recipients--an assessment of viral features and dysplasia.
    Blessing K; McLaren KM; Benton EC; Barr BB; Bunney MH; Smith IW; Beveridge GW
    Histopathology; 1989 Feb; 14(2):129-39. PubMed ID: 2540085
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human papillomavirus DNA in cutaneous primary and metastasized squamous cell carcinomas from patients with epidermodysplasia verruciformis.
    Ostrow RS; Bender M; Niimura M; Seki T; Kawashima M; Pass F; Faras AJ
    Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1634-8. PubMed ID: 6280194
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion.
    Stark LA; Arends MJ; McLaren KM; Benton EC; Shahidullah H; Hunter JA; Bird CC
    Br J Cancer; 1994 Feb; 69(2):222-9. PubMed ID: 8297718
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T cell defect in patients with epidermodysplasia verruciformis due to human papillomavirus type 3 and 5.
    Gliński W; Obałek S; Jabłońska S; Orth G
    Dermatologica; 1981; 162(3):141-7. PubMed ID: 6265297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection and analysis of human papillomavirus type 1 infection of skin warts from a dermatology clinic in Taiwan by southern hybridization.
    Sytwu HK; Sheu WJ; Shih JM; Chen SL
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Feb; 25(1):21-32. PubMed ID: 1339087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human papillomaviruses and skin cancer.
    Pfister H
    Semin Cancer Biol; 1992 Oct; 3(5):263-71. PubMed ID: 1335790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune reactions in epidermodysplasia verruciformis.
    Pyrhönen S; Jablonska S; Obałek S; Kuismanen E
    Br J Dermatol; 1980 Mar; 102(3):247-54. PubMed ID: 6245674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of an immunologically distinct papillomavirus from lesions of epidermodysplasia verruciformis.
    Pass F; Reissig M; Shah KV; Eisinger M; Orth G
    J Natl Cancer Inst; 1977 Oct; 59(4):1107-12. PubMed ID: 71354
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidermodysplasia verruciformis. A case associated with primary lymphatic dysplasia, depressed cell-mediated immunity, and Bowen's disease containing human papillomavirus 16 DNA.
    Ostrow RS; Manias D; Mitchell AJ; Stawowy L; Faras AJ
    Arch Dermatol; 1987 Nov; 123(11):1511-6. PubMed ID: 2823726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human papillomaviruses of different types in precancerous lesions of the uterine cervix: histologic, immunocytochemical and ultrastructural studies.
    Kadish AS; Burk RD; Kress Y; Calderin S; Romney SL
    Hum Pathol; 1986 Apr; 17(4):384-92. PubMed ID: 3007326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidermodysplasia verruciformis.
    Prystowsky SD; Herndon JH; Freeman RG; Boudreau C
    Am J Dis Child; 1976 Apr; 130(4):437-40. PubMed ID: 1266830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Absence of p53 protein overexpression in precancerous lesions of the vulva.
    Kohlberger PD; Kirnbauer R; Bancher D; Gitsch G; Reinthaller A; Leodolter S; Tschachler E; Kainz C; Breitenecker G
    Cancer; 1998 Jan; 82(2):323-7. PubMed ID: 9445189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients.
    de Jong-Tieben LM; Berkhout RJ; Smits HL; Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; ter Schegget J
    J Invest Dermatol; 1995 Sep; 105(3):367-71. PubMed ID: 7665914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.